Salusin-Alpha Restores Vessels in Pulmonary Hypertension 04/13/26
Welcome to Cardiology Today – Recorded April 13, 2026. This episode summarizes 5 key cardiology studies on topics like ischemic stroke and prehospital delay. Key takeaway: Salusin-Alpha Restores Vessels in Pulmonary Hypertension.
Article Links:
Article 1: Salusin-α Restores Vascular Relaxation and Remodeling in Pulmonary Hypertension. (Hypertension (Dallas, Tex. : 1979))
Article 2: Endothelial Senescence Drives Deleterious Endothelial-Adipocyte Cross-Talk in Patients With Heart Failure and Type 2 Diabetes. (JACC. Basic to translational science)
Article 3: Kinetics of Technetium-Labeled Cardiac Amyloid Radionuclide Imaging. (Circulation. Cardiovascular imaging)
Article 4: Intracranial Hemorrhage Patterns and Outcomes in Minor Stroke: Analysis of the TEMPO-2 Trial. (Stroke)
Article 5: Cost-Effectiveness of Prehospital Delay Reduction Versus Primary Stroke Prevention in US Adults With Type 2 Diabetes. (Stroke)
Full episode page: https://podcast.explainheart.com/podcast/salusin-alpha-restores-vessels-in-pulmonary-hypertension-04-13-26/
📚 Featured Articles
Article 1: Salusin-α Restores Vascular Relaxation and Remodeling in Pulmonary Hypertension.
Journal: Hypertension (Dallas, Tex. : 1979)
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41958393
Summary: This study demonstrated that salusin-alpha restored vascular relaxation and reversed vascular remodeling in pulmonary hypertension. Researchers found these effects by assessing pulmonary artery relaxation using isometric tension recording in isolated rat pulmonary arteries. They quantified reductions in pulmonary artery remodeling through histological morphometric analysis. The data indicated that salusin-alpha significantly alleviated the progressive increase in pulmonary arterial resistance characteristic of pulmonary hypertension.
Article 2: Endothelial Senescence Drives Deleterious Endothelial-Adipocyte Cross-Talk in Patients With Heart Failure and Type 2 Diabetes.
Journal: JACC. Basic to translational science
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41967191
Summary: Microvascular endothelial cells (MVECs) from subcutaneous adipose tissue of patients with type two diabetes mellitus and heart failure exhibited a senescent phenotype. These senescent cells displayed elevated senescence-associated secretory phenotype markers, reduced adenosine triphosphate production, and impaired angiogenic and proliferative capacities. When cocultured with healthy adipocytes, these senescent M. V. E. C. s drove adverse cross-talk, inducing a proinflammatory adipocyte phenotype with increased interleukin-6 expression. This research revealed how endothelial senescence contributes to chronic inflammation in this high-risk patient population.
Article 3: Kinetics of Technetium-Labeled Cardiac Amyloid Radionuclide Imaging.
Journal: Circulation. Cardiovascular imaging
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41961986
Summary: This study characterized the tracer kinetics of technetium-labeled bone-avid tracers used for diagnosing transthyretin cardiac amyloidosis. Researchers defined these kinetics using quantitative single-photon emission computed tomography with computed tomography in 24 subjects evaluated for the condition. The findings established the kinetic profile of these diagnostic agents. The study also addressed the use of hydroxymethylene diphosphonate as an alternative to technetium-99m pyrophosphate due to supply shortages, noting the limited comparative kinetic data available.
Article 4: Intracranial Hemorrhage Patterns and Outcomes in Minor Stroke: Analysis of the TEMPO-2 Trial.
Journal: Stroke
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41958392
Summary: This secondary analysis of the TEMPO-2 multicenter, randomized trial evaluated specific intracranial hemorrhage patterns and their impact on functional outcomes in patients with minor ischemic stroke. The study identified distinct predictors associated with intracranial hemorrhage within this patient population. It found that intracranial hemorrhage negatively impacts functional outcomes after ischemic stroke, with disproportionate effects observed in patients with minor stroke. The TEMPO-2 trial compared tenecteplase with nonthrombolytic standard care for patients within 12 hours of symptom onset.
Article 5: Cost-Effectiveness of Prehospital Delay Reduction Versus Primary Stroke Prevention in US Adults With Type 2 Diabetes.
Journal: Stroke
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41958382
Summary: This study determined the relative benefits and cost-effectiveness of reducing prehospital delay for acute ischemic stroke patients compared to implementing primary stroke prevention measures. The analysis focused on U. S. adults with type two diabetes, a population at high risk for acute ischemic stroke. Researchers utilized data from the National Health and Nutrition Examination Survey from 2015 to 2018. The findings established which intervention strategy offered greater cost-effectiveness in this specific high-risk group.
📝 Transcript
Today’s date is April 13, 2026. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Salusin-α Restores Vascular Relaxation and Remodeling in Pulmonary Hypertension. This study demonstrated that salusin-alpha restored vascular relaxation and reversed vascular remodeling in pulmonary hypertension. Researchers found these effects by assessing pulmonary artery relaxation using isometric tension recording in isolated rat pulmonary arteries. They quantified reductions in pulmonary artery remodeling through histological morphometric analysis. The data indicated that salusin-alpha significantly alleviated the progressive increase in pulmonary arterial resistance characteristic of pulmonary hypertension.
Article number two. Endothelial Senescence Drives Deleterious Endothelial-Adipocyte Cross-Talk in Patients With Heart Failure and Type 2 Diabetes. Microvascular endothelial cells (MVECs) from subcutaneous adipose tissue of patients with type two diabetes mellitus and heart failure exhibited a senescent phenotype. These senescent cells displayed elevated senescence-associated secretory phenotype markers, reduced adenosine triphosphate production, and impaired angiogenic and proliferative capacities. When cocultured with healthy adipocytes, these senescent M. V. E. C. s drove adverse cross-talk, inducing a proinflammatory adipocyte phenotype with increased interleukin-6 expression. This research revealed how endothelial senescence contributes to chronic inflammation in this high-risk patient population.
Article number three. Kinetics of Technetium-Labeled Cardiac Amyloid Radionuclide Imaging. This study characterized the tracer kinetics of technetium-labeled bone-avid tracers used for diagnosing transthyretin cardiac amyloidosis. Researchers defined these kinetics using quantitative single-photon emission computed tomography with computed tomography in 24 subjects evaluated for the condition. The findings established the kinetic profile of these diagnostic agents. The study also addressed the use of hydroxymethylene diphosphonate as an alternative to technetium-99m pyrophosphate due to supply shortages, noting the limited comparative kinetic data available.
Article number four. Intracranial Hemorrhage Patterns and Outcomes in Minor Stroke: Analysis of the TEMPO-2 Trial. This secondary analysis of the TEMPO-2 multicenter, randomized trial evaluated specific intracranial hemorrhage patterns and their impact on functional outcomes in patients with minor ischemic stroke. The study identified distinct predictors associated with intracranial hemorrhage within this patient population. It found that intracranial hemorrhage negatively impacts functional outcomes after ischemic stroke, with disproportionate effects observed in patients with minor stroke. The TEMPO-2 trial compared tenecteplase with nonthrombolytic standard care for patients within 12 hours of symptom onset.
Article number five. Cost-Effectiveness of Prehospital Delay Reduction Versus Primary Stroke Prevention in US Adults With Type 2 Diabetes. This study determined the relative benefits and cost-effectiveness of reducing prehospital delay for acute ischemic stroke patients compared to implementing primary stroke prevention measures. The analysis focused on U. S. adults with type two diabetes, a population at high risk for acute ischemic stroke. Researchers utilized data from the National Health and Nutrition Examination Survey from 2015 to 2018. The findings established which intervention strategy offered greater cost-effectiveness in this specific high-risk group.
Thank you for listening. Don’t forget to subscribe.
🔍 Keywords
ischemic stroke, prehospital delay, microvascular endothelial cells, technetium-labeled tracers, tenecteplase, endothelial senescence, pulmonary artery, single-photon emission computed tomography, adipocyte cross-talk, inflammation, minor stroke, acute ischemic stroke, type two diabetes mellitus, intracranial hemorrhage, heart failure, primary stroke prevention, functional outcomes, tracer kinetics, vascular remodeling, pulmonary hypertension, cost-effectiveness, TEMPO-2 trial, salusin-alpha, hydroxymethylene diphosphonate, National Health and Nutrition Examination Survey, cardiac imaging, transthyretin cardiac amyloidosis, vascular relaxation.
ℹ️ About
Concise summaries of cardiovascular research for professionals.
Subscribe • Share • Follow